TROY EDWARD WILSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TROY EDWARD WILSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TROY EDWARD WILSON. TROY EDWARD WILSON is a Director in PUMA BIOTECHNOLOGY, INC. ($PBYI) and a President and CEO in Kura Oncology, Inc. ($KURA) and a Director in Zosano Pharma Corp ($ZSAN) and a Director in Avidity Biosciences, Inc. ($RNA).
Address: C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BLVD., SUITE 2150 LOS ANGELES 90024 CA
Companies in which TROY EDWARD WILSON is an Insider
Avidity Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TROY EDWARD WILSON: Director
Holdings: 89,618 shares
Latest Transaction: Dec 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kura Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TROY EDWARD WILSON: President and CEO
Holdings: 1,620,017 shares
Current Value: $10,044,105
Latest Transaction: Jan 28 2021
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PUMA BIOTECHNOLOGY, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TROY EDWARD WILSON: Director
Holdings: 28,208 shares
Current Value: $954,841
Latest Transaction: Jun 17 2021
$PBYI Market Capitalization: $1.37B
$PBYI Previous Close: $33.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zosano Pharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TROY EDWARD WILSON: Director
Holdings: 3,000 shares
Current Value: $3,600
Latest Transaction: Jul 18 2019
$ZSAN Market Capitalization: $19.67M
$ZSAN Previous Close: $1.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TROY EDWARD WILSON
Sentiment: All, RNA, KURA, PBYI, ZSAN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | PBYI | PUMA BIOTECHNOLOGY ... | WILSON TROY EDWARD | Director | Grant | A | 0.00 | 27,858 | 0 | 28,208 | 350 to 28.2 K (+7,959.43 %) |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Option Exercise | A | 32.80 | 366,500 | 12,021,200 | 366,500 | |
| Jan 28 2021 | KURA | Kura Oncology, Inc ... | WILSON TROY EDWARD | President and CEO | Sell | J | 0.00 | 175,000 | 0 | 1,620,017 | 1.8 M to 1.6 M (-9.75 %) |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Buy | J | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Sell | J | 0.00 | 100,000 | 0 | 89,618 | 189.6 K to 89.6 K (-52.74 %) |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Buy | J | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 28 2020 | RNA | Avidity Bioscience ... | WILSON TROY EDWARD | Director | Sell | J | 0.00 | 100,000 | 0 | 89,618 | 189.6 K to 89.6 K (-52.74 %) |